Brainsway Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.080x

Brainsway Ltd cash flow conversion efficiency. Based on the latest financial reports, Brainsway Ltd (BWAY) has a cash flow conversion efficiency ratio of 0.080x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA6.35 Million ≈ $17.02K USD) by net assets (ILA79.19 Million ≈ $212.30K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Brainsway Ltd (2012–2025)

Cash flow conversion efficiency of Brainsway Ltd from 2012 to 2025. This chart illustrates how Brainsway Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BWAY stock price and chart for real-time trading data and today's change.

Brainsway Ltd Cash Flow Conversion Ratio Explained

Brainsway Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Brainsway Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brainsway Ltd ranked by their cash flow conversion efficiency. Also see Brainsway Ltd (BWAY) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Hung Ching Development & Construction Co Ltd
TW:2527
-0.026x
Sports Gear Co. Ltd
TW:6768
-0.047x
Vishnu Chemicals Limited
NSE:VISHNU
0.085x
Ningxia Xiaoming Agriculture & Animal Husbandry Co.Ltd
SHE:300967
N/A
SAMPYO Cement Co. Ltd
KQ:038500
0.061x
North American Financial 15
TO:FFN
0.060x
Issta Lines Ltd
TA:ISTA
0.034x
Eurocharm Holdings Co Ltd
TW:5288
0.027x

Annual Cash Flow Conversion Efficiency for Brainsway Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Brainsway Ltd from 2012 to 2025. Review free cash flow generation of Brainsway Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ILA78.27 Million
≈ $209.83K
ILA18.02 Million
≈ $48.31K
0.230x +39.32%
2024-12-31 ILA62.31 Million
≈ $167.06K
ILA10.30 Million
≈ $27.61K
0.165x +435.19%
2023-12-31 ILA41.58 Million
≈ $111.48K
ILA1.28 Million
≈ $3.44K
0.031x +114.36%
2022-12-31 ILA45.40 Million
≈ $121.71K
ILA-9.76 Million
≈ $-26.16K
-0.215x -1494.00%
2021-12-31 ILA57.32 Million
≈ $153.68K
ILA884.00K
≈ $2.37K
0.015x +121.08%
2020-12-31 ILA19.63 Million
≈ $52.64K
ILA-1.44 Million
≈ $-3.85K
-0.073x +75.55%
2019-12-31 ILA24.22 Million
≈ $64.93K
ILA-7.24 Million
≈ $-19.42K
-0.299x +44.89%
2018-12-31 ILA6.95 Million
≈ $18.64K
ILA-3.77 Million
≈ $-10.12K
-0.543x -99.13%
2017-12-31 ILA12.72 Million
≈ $34.10K
ILA-3.47 Million
≈ $-9.29K
-0.273x -16.72%
2016-12-31 ILA10.29 Million
≈ $27.58K
ILA-2.40 Million
≈ $-6.44K
-0.233x +33.85%
2015-12-31 ILA12.89 Million
≈ $34.57K
ILA-4.55 Million
≈ $-12.20K
-0.353x -44.97%
2014-12-31 ILA15.58 Million
≈ $41.76K
ILA-3.79 Million
≈ $-10.17K
-0.244x -50.97%
2013-12-31 ILA14.65 Million
≈ $39.28K
ILA-2.36 Million
≈ $-6.34K
-0.161x +74.07%
2012-12-31 ILA9.01 Million
≈ $24.15K
ILA-5.60 Million
≈ $-15.02K
-0.622x --

About Brainsway Ltd

TA:BWAY Israel Medical Devices
Market Cap
$394.54 Million
ILA147.16 Billion ILA
Market Cap Rank
#13128 Global
#140 in Israel
Share Price
ILA3656.00
Change (1 day)
+3.72%
52-Week Range
ILA2423.00 - ILA5074.00
All Time High
ILA5074.00
About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more